Ibtrozi Prospects Asserts Nuvation Bio Inc. (NUVB) as one of the Best Healthcare Penny Stocks

Nuvation Bio Inc. (NYSE:NUVB) is one of the best healthcare penny stocks to buy according to hedge funds. On April 8, analysts at Truist Securities reiterated a Buy rating on Nuvation Bio Inc (NYSE:NUVB) with a $12 price target. The positive stance follows a meeting with the company’s management.

Ibtrozi Prospects Asserts Nuvation Bio Inc. (NUVB) as one of the Best Healthcare Penny Stocks

White medicinal tablets. Photo by Kaboompics.com

The meetings centered on the launch of Ibtrozi, the company’s FDA-approved once-daily inhibitor for treating adults with advanced or metastatic non-small cell lung cancer. Management confirmed the launch of the candidate drug, with prospects of it adding about 200 points per quarter in the near term.

The company is already capitalizing on patient mix shifting towards the use of Ibtrozi as a first line of defense, with the potential to expand as testing increases. Last year, Nuvation Bio generated $15.7 million in net product value from the launch of Ibtrozi, with 216 new patients starting treatment in the fourth quarter. In addition, Truist Securities touted the company’s Safu treatment prospects in Glioma.

Nuvation Bio Inc. (NYSE:NUVB) is a commercial-stage biopharmaceutical company focused on developing and commercializing novel, targeted oncology medicines for difficult-to-treat cancers. The company targets drug resistance and aims to improve patient quality of life through a deep pipeline of small molecule inhibitors and drug-drug conjugates.

While we acknowledge the risk and potential of NUVB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NUVB and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Penny Stocks That Aren’t Scams: Best Cheap Stocks to Buy and 8 Best Small-Cap Value Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.